- Advanced search
- Immuno Portal
- Malaria Portal
Molecular properties generated using the CDK
These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.✖
1. Close DR. (2001)
Matrix metalloproteinase inhibitors in rheumatic diseases.
Ann. Rheum. Dis., 60 Suppl 3: iii62-7. [PMID:11890658]
2. Hemmings FJ, Farhan M, Rowland J, Banken L, Jain R. (2001)
Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis.
Rheumatology (Oxford), 40 (5): 537-43. [PMID:11371662]
3. Lein M, Jung K, Ortel B, Stephan C, Rothaug W, Juchem R, Johannsen M, Deger S, Schnorr D, Loening S et al.. (2002)
The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
Oncogene, 21 (13): 2089-96. [PMID:11960381]